India Emerging Infectious Disease Diagnostics Market
India Emerging Infectious Disease Diagnostics Market, By Technology (Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT), Next-Generation Sequencing (NGS), Immunodiagnostics); By Type of Infections (Bacterial, Viral, Fungal); By Disease Type (Respiratory Infections, Sexually Transmitted Infections (STIs), Gastrointestinal Infections); By Application (Laboratory Testing, Point-of-Care Testing); By End User (Hospitals & Clinics, Diagnostic Laboratories); By Region (North India, South India, East India, West India), Trend Analysis, Competitive Landscape & Forecast, 2019–2030
- Published Date: August 2024
- Report ID: BWC24638
- Available Format: PDF
- Page: 200
Report Overview
Rising prevalence of infectious diseases, growing private healthcare sector, rapid advancements in diagnostic technologies, and growing awareness about early diagnosis are expected to drive India Emerging Infectious Disease Diagnostics Market during the forecast period between 2024 and 2030.India Emerging Infectious Disease Diagnostics Market – Industry Trends & Forecast Report, 2030
India Emerging Infectious Disease Diagnostics Market size was estimated at USD 368.89 million in 2023. During the forecast period between 2024 and 2030, India Emerging Infectious Disease Diagnostics Market size is projected to grow at a CAGR of 10.13% reaching a value of USD 719.27 million by 2030. Prominent drivers of the market include significant advancements and innovations in diagnostic methods, particularly with the adoption of next-generation sequencing and the rising demand for rapid testing, as seen during the COVID-19 pandemic. The market is transitioning from an emerging phase to a growth phase, fueled by new technologies and devices that offer faster, more efficient, and cost-effective solutions. These developments have positioned infectious disease diagnostics as a cornerstone in the evolution of modern biotechnology, clinical diagnostics, and pathogen research. Accurate and timely diagnosis, effective patient management, enhanced public health surveillance, and continuous research and development are key factors contributing to the market's growth and its crucial role in healthcare and public health.
Emerging Infectious Disease Diagnostics – Overview
Emerging Infectious Disease Diagnostics refers to the tools, tests, and technologies used to detect and identify pathogens responsible for newly identified or re-emerging infectious diseases. These diagnostics are crucial in identifying infectious agents rapidly and accurately, allowing for timely intervention, treatment, and control of diseases that may have significant public health implications. Emerging infectious diseases are typically those that have recently appeared within a population or those whose incidence or geographic range is rapidly increasing or threatens to increase in the coming years. Diagnostic tools in this field often involve advanced techniques such as molecular diagnostics, next-generation sequencing, and rapid point-of-care tests, which are essential for managing outbreaks and mitigating the spread of these diseases.
India Emerging Infectious Disease Diagnostics Market
Growth Drivers
Rapid Advancements in Diagnostic Technologies
Rapid advancements in diagnostic technologies are significantly propelling the India Emerging Infectious Disease Diagnostics Market. The Indian government, through agencies like the Department of Biotechnology (DBT) and the Indian Council of Medical Research (ICMR), is fervently supporting research initiatives aimed at developing innovative diagnostic tools. These initiatives foster groundbreaking advancements that enhance the accuracy, speed, and efficiency of diagnostics for emerging infectious diseases. The continuous investment in research and development is driving the evolution of diagnostic technologies, enabling healthcare providers to implement swift and precise interventions, thereby improving public health outcomes.
Rising Awareness about Early Diagnosis
Rising awareness about the importance of early diagnosis is playing a crucial role in boosting the India Emerging Infectious Disease Diagnostics Market. In India, there is a growing recognition of the critical importance of detecting infectious diseases early to ensure effective disease management and curb transmission. Government initiatives, such as the Ayushman Bharat scheme, are instrumental in promoting preventive care and establishing health and wellness centers nationwide, which contribute to early disease detection. This heightened awareness is driving the demand for advanced diagnostic tools that can deliver quick and accurate results, emphasizing the vital role of early diagnosis in improving health outcomes.
Challenges
Limited Healthcare Infrastructure
Limited healthcare infrastructure significantly restrains the growth of the India Emerging Infectious Disease Diagnostics Market. Across regions, inadequate healthcare facilities, a shortage of trained medical professionals, and insufficient access to advanced diagnostic tools hinder the effective management and diagnosis of infectious diseases. Rural and underserved areas are particularly affected, where the lack of modern healthcare infrastructure limits the reach and impact of emerging diagnostic technologies. This gap in infrastructure not only slows the adoption of innovative diagnostics but also exacerbates the challenges in addressing the rising prevalence of infectious diseases across the country.
Impact of Escalating Geopolitical Tensions on India Emerging Infectious Disease Diagnostics Market
Escalating geopolitical tensions among countries across regions could have a significant impact on the growth of India Emerging Infectious Disease Diagnostics Market. These tensions can disrupt global supply chains, leading to shortages of critical diagnostic equipment and materials. Additionally, strained international relations may hinder collaborative research efforts and limit access to advanced technologies from other countries. Geopolitical instability can also divert government focus and resources away from healthcare initiatives, further exacerbating challenges in managing infectious diseases. The combined effect of these factors could slow the development and deployment of innovative diagnostic tools, restraining the market's growth in India.
India Emerging Infectious Disease Diagnostics Market
Segmental Coverage
India Emerging Infectious Disease Diagnostics Market – By Technology
By technology, India Emerging Infectious Disease Diagnostics Market is divided into Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT), Next-Generation Sequencing (NGS), and Immunodiagnostics segments. The PCR segment holds the highest share in India Emerging Infectious Disease Diagnostics Market by technology, due to its unparalleled accuracy, sensitivity, and rapid detection capabilities. PCR technology is widely regarded as the gold standard for diagnosing infectious diseases, allowing for the precise identification of pathogens at the molecular level. Its ability to detect even minute quantities of viral or bacterial DNA makes it invaluable in early diagnosis and disease management. Moreover, the increasing prevalence of infectious diseases in India, coupled with the growing demand for reliable diagnostic tools, has further solidified PCR's dominance in the market. The technology's ongoing advancements and widespread adoption continue to drive its leading position in the industry.
India Emerging Infectious Disease Diagnostics Market – By Type of Infections
Based on type of infections, India Emerging Infectious Disease Diagnostics Market is divided into Bacterial, Viral, and Fungal segments. The bacterial segment holds the highest share in India Emerging Infectious Disease Diagnostics Market by type of infections. India's high population density, coupled with inadequate sanitation and hygiene practices, creates a fertile environment for the spread of bacterial diseases. The tropical climate in many regions further exacerbates this issue, making bacterial infections more prevalent. Rapid urbanization has led to overcrowded cities, where infectious diseases like tuberculosis, typhoid, and cholera can easily spread. Compounding these challenges, antibiotic resistance has become a significant concern due to the misuse and overuse of antibiotics, resulting in drug-resistant bacterial strains. Consequently, there is a growing need for advanced diagnostic tests to accurately identify the bacteria involved and determine the most effective treatment options.
India Emerging Infectious Disease Diagnostics Market – By Disease Type
By disease type, India Emerging Infectious Disease Diagnostics Market is divided into Respiratory Infections, Sexually Transmitted Infections (STIs), and Gastrointestinal Infections segments.
India Emerging Infectious Disease Diagnostics Market – By Application
Based on application, India Emerging Infectious Disease Diagnostics Market is bifurcated into Laboratory Testing and Point-of-Care Testing segments. The laboratory testing segment holds a higher share in India Emerging Infectious Disease Diagnostics Market by application, due to its superior accuracy, comprehensive analysis, and ability to handle a high volume of tests. Laboratory-based diagnostics are essential for detecting a wide range of infectious diseases, offering in-depth analysis that point-of-care tests may not provide. These tests are conducted in well-equipped facilities by trained professionals, ensuring precision in diagnosing complex infections. Additionally, laboratories can process large numbers of samples, making them critical in managing outbreaks and conducting surveillance. The reliability and thoroughness of laboratory testing have established its dominance in the market.
India Emerging Infectious Disease Diagnostics Market – By End User
Based on end user, India Emerging Infectious Disease Diagnostics Market is bifurcated into Hospitals & Clinics and Diagnostic Laboratories segments. The hospitals & clinics segment holds a higher share in India Emerging Infectious Disease Diagnostics Market by end user. Hospitals and clinics are pivotal in infectious disease diagnostics, serving as key locations for patient evaluation and testing. They utilize point-of-care testing (PoCT) for quick results and immediate management, but also depend on laboratory testing for more thorough analysis. Some healthcare facilities have advanced on-site laboratories, while others partner with external labs for specialized tests. These laboratories use a range of methods, including molecular techniques like PCR and sequencing, serological assays, and culture-based approaches, to accurately identify and characterize infectious agents. This combination of immediate and in-depth testing ensures effective diagnosis and treatment of infections.
India Emerging Infectious Disease Diagnostics Market – By Region
The in-depth research report on India Emerging Infectious Disease Diagnostics Market covers the market in the country’s major regions: North India, South India, East India, and West India regions. West India holds the highest share in India Emerging Infectious Disease Diagnostics Market and is expected to maintain its dominance during the forecast period. West India region, which includes major urban centers such as Mumbai and Pune, benefits from its high population density, creating a significant demand for diagnostic services. The dense population heightens the risk of rapid disease transmission, leading to a strong need for advanced diagnostic capabilities. West India's well-established healthcare infrastructure, including numerous hospitals, diagnostic centers, and research institutions, supports its market leadership by ensuring comprehensive and high-quality diagnostic services. Additionally, the presence of prestigious research institutions in the region drives innovation in diagnostic technologies, further solidifying West India's position as a key player in the diagnostics market. The interplay between these advanced research facilities and the robust healthcare system fosters an environment conducive to the growth and development of diagnostic solutions, reinforcing West India's dominant market share.
Competitive Landscape
Major players operating in India Emerging Infectious Disease Diagnostics Market include Abbott Laboratories, Becton Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories Inc, DANAHER CORPORATION, DiaSorin SpA, Hoffmann-La Roche Ltd, QIAGEN NV, Thermo Fisher Scientific Inc, and Siemens Healthineers AG. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.
Recent Developments
-
In October 2023 - Deenanath Mangeshkar Hospital recently inaugurated the 'Direct Relief Centre of Excellence in Infectious Diseases.' Established in collaboration with the US-based non-profit Direct Relief, the center is dedicated to providing high-quality diagnostic and therapeutic care for infectious diseases, accessible to all social and economic groups. It will also focus on research and training, offering academic programs such as fellowships and workshops.
-
In February 2023 - Thermo Fisher Scientific Inc. and biotech leader Mylab formed a strategic partnership to develop advanced test kits for infectious diseases. The collaboration combines Thermo Fisher's molecular diagnostics expertise with Mylab's innovative technology, aiming to meet the increasing demand for accurate and efficient testing solutions.
Scope of the Report
Attributes |
Details |
Years Considered |
Historical Data – 2019–2030 |
Base Year – 2023 |
|
Estimated Year – 2024 |
|
Forecast Period – 2024–2030 |
|
Facts Covered |
USD Million |
Market Coverage |
India |
Product/ Service Segmentation |
Technology, Type of Infections, Disease Type, Application, End User, Region |
Key Players |
Abbott Laboratories, Becton Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories Inc, DANAHER CORPORATION, DiaSorin SpA, Hoffmann-La Roche Ltd, QIAGEN NV, Thermo Fisher Scientific Inc, Siemens Healthineers AG |
By Technology
-
Polymerase Chain Reaction (PCR)
-
Isothermal Nucleic Acid Amplification Technology (INAAT)
-
Next-Generation Sequencing (NGS)
-
Immunodiagnostics
By Type of Infections
-
Bacterial
-
Viral
-
Fungal
By Disease Type
-
Respiratory Infections
-
Sexually Transmitted Infections (STIs)
-
Gastrointestinal Infections
By Application
-
Laboratory Testing
-
Point-of-Care Testing
By End User
-
Hospitals & Clinics
-
Diagnostic Laboratories
By Region
-
North India
-
South India
-
East India
-
West India
- Research Framework
- Research Objective
- Product Overview
- Market Segmentation
- Executive Summary
- India Emerging Infectious Disease Diagnostics Market Insights
- Industry Value Chain Analysis
- DROC Analysis
- Growth Drivers
- Rising prevalence of infectious diseases
- Growing private healthcare sector
- Rapid advancements in diagnostic technologies
- Rising awareness about early diagnosis
- Restraints
- Limited healthcare infrastructure
- Low healthcare expenditure
- Lack of skilled personnel
- Opportunities
- Increasing emphasis on preventive healthcare
- Growth of telemedicine
- Creasing government initiatives
- Challenges
- Presence of counterfeit and substandard diagnostic products
- Data Privacy and Security
- Price Sensitivity among significant portion of the Indian population
- Growth Drivers
- Technological Advancements/Recent Developments
- Regulatory Framework
- Porter’s Five Forces Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of New Entrants
- Threat of Substitutes
- Intensity of Rivalry
- India Emerging Infectious Disease Diagnostics Market: Pricing Analysis
- India Emerging Infectious Disease Diagnostics Market: Marketing Strategies
- India Emerging Infectious Disease Diagnostics Market Overview
- Market Size & Forecast, 2019–2030
- By Value (USD Million)
- Market Share & Forecast
- By Technology
- Polymerase Chain Reaction (PCR)
- Isothermal Nucleic Acid Amplification Technology (INAAT)
- Next-Generation Sequencing (NGS)
- Immunodiagnostics
- Other Technologies
- By Type of Infections
- Bacterial
- Viral
- Fungal
- Others
- By Disease Type
- Respiratory Infections
- Sexually Transmitted Infections (STIs)
- Gastrointestinal Infections
- Others
- By Application
- Laboratory Testing
- Point-of-Care Testing
- By End User
- Hospitals and Clinics
- Diagnostic Laboratories
- Others
- By Region
- North India
- South India
- East India
- West India
- By Technology
- Market Size & Forecast, 2019–2030
- North India Emerging Infectious Disease Diagnostics Market Overview
- Market Size & Forecast, 2019–2030
- By Value (USD Million)
- Market Share & Forecast
- By Technology
- By Type of Infections
- By Disease Type
- By Application
- By End User
- Market Size & Forecast, 2019–2030
- South India Emerging Infectious Disease Diagnostics Market Overview
- Market Size & Forecast, 2019–2030
- By Value (USD Million)
- Market Share & Forecast
- By Technology
- By Type of Infections
- By Disease Type
- By Application
- By End User
- Market Size & Forecast, 2019–2030
- East India Emerging Infectious Disease Diagnostics Market Overview
- Market Size & Forecast, 2019–2030
- By Value (USD Million)
- Market Share & Forecast
- By Technology
- By Type of Infections
- By Disease Type
- By Application
- By End User
- Market Size & Forecast, 2019–2030
- West India Emerging Infectious Disease Diagnostics Market Overview
- Market Size & Forecast, 2019–2030
- By Value (USD Million)
- Market Share & Forecast
- By Technology
- By Type of Infections
- By Disease Type
- By Application
- By End User
- Market Size & Forecast, 2019–2030
- Competitive Landscape
- List of Key Players and Their Offerings
- India Emerging Infectious Disease Diagnostics Company Market Share Analysis, 2023
- Competitive Benchmarking, By Operating Parameters
- Key Strategic Developments (Mergers, Acquisitions, Partnerships)
- Impact of Escalating Geopolitical Tensions in India Emerging Infectious Disease Diagnostics Market
- Company Profiles (Company Overview, Financial Matrix, Competitive landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)
- Abbott Laboratories
- Becton, Dickinson and Company
- bioMérieux S.A.
- Bio-Rad Laboratories, Inc.
- DANAHER CORPORATION
- DiaSorin S.p.A.
- Hoffmann-La Roche Ltd
- QIAGEN N.V.
- Thermo Fisher Scientific Inc.
- Siemens Healthineers AG
- Other Prominent Players
- Key Strategic Recommendations
- Research Methodology
- Qualitative Research
- Primary & Secondary Research
- Quantitative Research
- Market Breakdown & Data Triangulation
- Secondary Research
- Primary Research
- Breakdown of Primary Research Respondents, By Region
- Assumption & Limitation
- Qualitative Research
* Financial information of non-listed companies will be provided as per availability
**The segmentation and the companies are subjected to modifications based on in-depth secondary for the final deliverable
List of Figures
Figure 1 India Emerging Infectious Disease Diagnostics Market Segmentation
Figure 2 India Emerging Infectious Disease Diagnostics Market Value Chain Analysis
Figure 3 Company Market Share Analysis, 2023
Figure 4 India Emerging Infectious Disease Diagnostics Market Size, By Value (USD Million), 2019–2030
Figure 5 India Emerging Infectious Disease Diagnostics Market Share, By Technology, By Value (USD Million), 2019–2030
Figure 6 India Emerging Infectious Disease Diagnostics Market Share, By Type of Infections, By Value (USD Million), 2019–2030
Figure 7 India Emerging Infectious Disease Diagnostics Market Share, By Disease Type, By Value (USD Million), 2019–2030
Figure 8 India Emerging Infectious Disease Diagnostics Market Share, By Application, By Value (USD Million), 2019–2030
Figure 9 India Emerging Infectious Disease Diagnostics Market Share, By End User, By Value (USD Million), 2019–2030
Figure 10 India Emerging Infectious Disease Diagnostics Market Share, By Region, By Value (USD Million), 2019–2030
Figure 11 North India Emerging Infectious Disease Diagnostics Market Size, By Value (USD Million), 2019–2030
Figure 12 North India Emerging Infectious Disease Diagnostics Market Share, By Technology, By Value (USD Million), 2019–2030
Figure 13 North India Emerging Infectious Disease Diagnostics Market Share, By Type of Infections, By Value (USD Million), 2019–2030
Figure 14 North India Emerging Infectious Disease Diagnostics Market Share, By Disease Type, By Value (USD Million), 2019–2030
Figure 15 North India Emerging Infectious Disease Diagnostics Market Share, By Application, By Value (USD Million), 2019–2030
Figure 16 North India Emerging Infectious Disease Diagnostics Market Share, By End User, By Value (USD Million), 2019–2030
Figure 17 South India Emerging Infectious Disease Diagnostics Market Size, By Value (USD Million), 2019–2030
Figure 18 South India Emerging Infectious Disease Diagnostics Market Share, By Technology, By Value (USD Million), 2019–2030
Figure 19 South India Emerging Infectious Disease Diagnostics Market Share, By Type of Infections, By Value (USD Million), 2019–2030
Figure 20 South India Emerging Infectious Disease Diagnostics Market Share, By Disease Type, By Value (USD Million), 2019–2030
Figure 21 South India Emerging Infectious Disease Diagnostics Market Share, By Application, By Value (USD Million), 2019–2030
Figure 22 India Emerging Infectious Disease Diagnostics Market Share, By End User, By Value (USD Million), 2019–2030
Figure 23 East India Emerging Infectious Disease Diagnostics Market Size, By Value (USD Million), 2019–2030
Figure 24 East India Emerging Infectious Disease Diagnostics Market Share, By Technology, By Value (USD Million), 2019–2030
Figure 25 East India Emerging Infectious Disease Diagnostics Market Share, By Type of Infections, By Value (USD Million), 2019–2030
Figure 26 East India Emerging Infectious Disease Diagnostics Market Share, By Disease Type, By Value (USD Million), 2019–2030
Figure 27 East India Emerging Infectious Disease Diagnostics Market Share, By Application, By Value (USD Million), 2019–2030
Figure 28 East India Emerging Infectious Disease Diagnostics Market Share, By End User, By Value (USD Million), 2019–2030
Figure 29 West India Emerging Infectious Disease Diagnostics Market Size, By Value (USD Million), 2019–2030
Figure 30 West India Emerging Infectious Disease Diagnostics Market Share, By Technology, By Value (USD Million), 2019–2030
Figure 31 West India Emerging Infectious Disease Diagnostics Market Share, By Type of Infections, By Value (USD Million), 2019–2030
Figure 32 West India Emerging Infectious Disease Diagnostics Market Share, By Disease Type, By Value (USD Million), 2019–2030
Figure 33 West India Emerging Infectious Disease Diagnostics Market Share, By Application, By Value (USD Million), 2019–2030
Figure 34 West India Emerging Infectious Disease Diagnostics Market Share, By End User, By Value (USD Million), 2019–2030
List of Tables
Table 1 India Emerging Infectious Disease Diagnostics Market Size, By Value (USD Million), 2019–2030
Table 2 India Emerging Infectious Disease Diagnostics Market Share, By Technology, By Value (USD Million), 2019–2030
Table 3 India Emerging Infectious Disease Diagnostics Market Share, By Type of Infections, By Value (USD Million), 2019–2030
Table 4 India Emerging Infectious Disease Diagnostics Market Share, By Disease Type, By Value (USD Million), 2019–2030
Table 5 India Emerging Infectious Disease Diagnostics Market Share, By Application, By Value (USD Million), 2019–2030
Table 6 India Emerging Infectious Disease Diagnostics Market Share, By End User, By Value (USD Million), 2019–2030
Table 7 India Emerging Infectious Disease Diagnostics Market Share, By Region, By Value (USD Million), 2019–2030
Table 8 North India Emerging Infectious Disease Diagnostics Market Size, By Value (USD Million), 2019–2030
Table 9 North India Emerging Infectious Disease Diagnostics Market Share, By Technology, By Value (USD Million), 2019–2030
Table 10 North India Emerging Infectious Disease Diagnostics Market Share, By Type of Infections, By Value (USD Million), 2019–2030
Table 11 North India Emerging Infectious Disease Diagnostics Market Share, By Disease Type, By Value (USD Million), 2019–2030
Table 12 North India Emerging Infectious Disease Diagnostics Market Share, By Application, By Value (USD Million), 2019–2030
Table 13 North India Emerging Infectious Disease Diagnostics Market Share, By End User, By Value (USD Million), 2019–2030
Table 14 South India Emerging Infectious Disease Diagnostics Market Size, By Value (USD Million), 2019–2030
Table 15 South India Emerging Infectious Disease Diagnostics Market Share, By Technology, By Value (USD Million), 2019–2030
Table 16 South India Emerging Infectious Disease Diagnostics Market Share, By Type of Infections, By Value (USD Million), 2019–2030
Table 17 South India Emerging Infectious Disease Diagnostics Market Share, By Disease Type, By Value (USD Million), 2019–2030
Table 18 South India Emerging Infectious Disease Diagnostics Market Share, By Application, By Value (USD Million), 2019–2030
Table 19 South India Emerging Infectious Disease Diagnostics Market Share, By End User, By Value (USD Million), 2019–2030
Table 20 East India Emerging Infectious Disease Diagnostics Market Size, By Value (USD Million), 2019–2030
Table 21 East India Emerging Infectious Disease Diagnostics Market Share, By Technology, By Value (USD Million), 2019–2030
Table 22 East India Emerging Infectious Disease Diagnostics Market Share, By Type of Infections, By Value (USD Million), 2019–2030
Table 23 East India Emerging Infectious Disease Diagnostics Market Share, By Disease Type, By Value (USD Million), 2019–2030
Table 24 East India Emerging Infectious Disease Diagnostics Market Share, By Application, By Value (USD Million), 2019–2030
Table 25 East India Emerging Infectious Disease Diagnostics Market Share, By End User, By Value (USD Million), 2019–2030
Table 26 West India Emerging Infectious Disease Diagnostics Market Size, By Value (USD Million), 2019–2030
Table 27 West India Emerging Infectious Disease Diagnostics Market Share, By Technology, By Value (USD Million), 2019–2030
Table 28 West India Emerging Infectious Disease Diagnostics Market Share, By Type of Infections, By Value (USD Million), 2019–2030
Table 29 West India Emerging Infectious Disease Diagnostics Market Share, By Disease Type, By Value (USD Million), 2019–2030
Table 30 West India Emerging Infectious Disease Diagnostics Market Share, By Application, By Value (USD Million), 2019–2030
Table 31 West India Emerging Infectious Disease Diagnostics Market Share, By End User, By Value (USD Million), 2019–2030
Table 32 Abbott Laboratories Company Overview
Table 33 Abbott Laboratories Financial Overview
Table 34 Becton, Dickinson and Company - Company Overview
Table 35 Becton, Dickinson and Company Financial Overview
Table 36 bioMérieux S.A. Company Overview
Table 37 bioMérieux S.A. Financial Overview
Table 38 Bio-Rad Laboratories, Inc. Company Overview
Table 39 Bio-Rad Laboratories, Inc. Financial Overview
Table 40 DANAHER CORPORATION Company Overview
Table 41 DANAHER CORPORATION Financial Overview
Table 42 DiaSorin S.p.A. Company Overview
Table 43 DiaSorin S.p.A. Financial Overview
Table 44 Hoffmann-La Roche Ltd Company Overview
Table 45 Hoffmann-La Roche Ltd Financial Overview
Table 46 QIAGEN N.V. Company Overview
Table 47 QIAGEN N.V. Financial Overview
Table 48 Thermo Fisher Scientific Inc. Company Overview
Table 49 Thermo Fisher Scientific Inc. Financial Overview
Table 50 Siemens Healthineers AG Company Overview
Table 51 Siemens Healthineers AG Financial Overview
Market Segmentation
To request a free sample copy of this report, please complete the form below.
We value your investment and offer free customization with every report to fulfil your exact research needs.
Frequently Asked Questions (FAQs):
RELATED REPORTS
WHY CHOOSE US
-
24/7 Research Support
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
-
Custom Research Service
Ask the Analyst to customize an exclusive study to serve your research needs
-
Quality & Accuracy
Ask the Analyst to customize an exclusive study to serve your research needs
-
Data Visualization
As the business world is changing dynamically every day. We need to stay pin point in relation to data management and optimum data utilization
-
Information security
We never share your personal and confidential information. Your personal information is safe and secure with us.